This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kristin Dickschen - Innovator in Pharmaceutical Formulations
Introduction
Kristin Dickschen is an accomplished inventor based in Düsseldorf, Germany. She is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. Kristin has made significant contributions to the field of drug formulations, focusing on the interplay between genotypes and phenotypes in medication effectiveness.
Latest Patent Applications
Kristin Dickschen's notable patent application is titled "Genotype- or Phenotype-Based Drug Formulations." This invention relates to a combination of two or more pharmaceutically active substances, where at least one is a metabolic product of another. The application emphasizes the importance of selecting dosages that account for variability in the conversion of the parent substance to the metabolite in individuals with different genetic backgrounds.
Conclusion
Kristin Dickschen's innovative work in drug formulations highlights the importance of personalized medicine. Her research aims to improve therapeutic outcomes by considering individual genetic differences in drug metabolism.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile